What is the current target price for the Candel Therapeutics Inc share?

The average Candel Therapeutics Inc target price is $11.00. This is 77.42% higher than the current share price. 1 Analyst has issued a Candel Therapeutics Inc price target 2025.

How high will the Candel Therapeutics Inc share rise?

No reliable answer can be given as to how high the Candel Therapeutics Inc share will rise. The performance of shares, including the Candel Therapeutics Inc share, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Candel Therapeutics Inc share today?

The performance of Candel Therapeutics Inc shares on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Candel Therapeutics Inc share fall?

The decline in Candel Therapeutics Inc shares may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's share price could be in a certain period of time, usually 12 months.

Candel Therapeutics Inc Forecast, price target & analysts

$6.20

5.26% day before yesterday

Nasdaq, Jun 28, 10:18 pm CET

ISIN

US1374041093

Symbol

CADL

Reports

Quarter | Year

Index

NASDAQ Composite

Sector

Services

Industry

Various services

Overview Dividends Analysts Charts News Strategies

Candel Therapeutics Inc Target price 2024 - Analyst rating & recommendation

Candel Therapeutics Inc Classifications & Recommendation:

Buy

100%

Candel Therapeutics Inc Target price

Target price	$11.00
Course	$6.20
Price potential	77.42% register free of charge
Number of estimates	1

	1 Analyst has issued a Candel Therapeutics Inc price target 2025. The average Candel Therapeutics Inc target price is $11.00. This is 77.42% register free of charge higher than the current share price.
	A rating was issued by 1 analysts: 1 Analysts recommend Candel Therapeutics Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst estimates: Analysts believe that the Candel Therapeutics Inc share has an average upside potential 2025 of 77.42% register free of charge . Most analysts recommend the Candel Therapeutics Inc share at Purchase.

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 & 2026

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Forecast
Earnings per share $	-1.31	-0.97
	101.54%	25.95%
P/E ratio		negative

The average Candel Therapeutics Inc <a href=/blog/eps>EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2023.

This results in the following potential growth figures and future valuations:

2023	$-1.31	101.54%
2024	$-0.97 25.95% unlock

Current	-4.81	321.93%
2024	-1.59 66.94% unlock

Candel Therapeutics Inc...

Discover more stocks with a high price target

Valneva 193.86%

CureVac N.V. 152.91%

Plug Power Inc. 106.89%

Bavarian Nordic 55.50%

Teamviewer 54.84%

Zalando 48.21%

Alibaba Group Holding Ltd 45.34%

Daimler Truck 44.32%

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

Start now